Have a personal or library account? Click to login
p-Synephrine and its various pharmacological effects Cover

Abstract

There is a number of diseases for which, scientists are constantly looking for a promising new treatments. Isolation of novel substances with biological activity from plants gives hope for its use in treatment. In this review, we focused on the biological activity of p-synephrine (4-(2-aminoethyl)phenol) which was previously confirmed during both in vitro and in vivo tests. The main part of the review is dedicated to the anti-obesity activity of p-synephrine, as obesity is a disease of contemporary civilization. However, synephrine also possesses anti-diabetic, anti-inflammatory and antidepressant activity and it is confirmed to be a hypotensive agent in portal hypertension. The review also emphasize that, based on current knowledge, the use of p-synephrine appears to be exceedingly safe with only limited range of side effects. Therefore, it seems that this substance may be of great importance in the pharmacotherapy of many disease states and further research is necessary.

DOI: https://doi.org/10.2478/cipms-2021-0031 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 169 - 173
Submitted on: Jul 19, 2021
|
Accepted on: Sep 17, 2021
|
Published on: Dec 30, 2021
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Wojciech Ziemichod, Ewa Gibula-Tarlowska, Jolanta H. Kotlinska, Pawel Grochecki, Ewa Kedzierska, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.